Australian Biotechnology News

Stories about: ATC

  • +

    Avexa appoints new chairman 09/07/2010 11:39:00

    HIV drug company Avexa has appointed industry veteran Joe Baini as its new chairman after shareholders voted on Tuesday to remove his predecessor Nathan Drona and virtually the company’s entire board.
  • +

    Avexa axes board 06/07/2010 17:01:00

    Shareholders in Avexa today voted resoundingly in favour of ousting existing chairman and director Nathan Drona along with the company’s entire board.
  • +

    Avexa reels from HIV drug dropout 13/05/2010 13:00:00

    Positive phase III results weren't enough to save apricitabine, the flagship HIV treatment being developed by Melbourne-based Avexa.
  • +

    Positive results for Avexa 16/03/2009 15:31:00

    Avexa reports impressive results for apricitabine in HIV+ patients
  • +

    Big week for Australian biotechs 12/03/2008 15:49:21

    Progen goes into Phase III and ChemGenex Phase II, Bionomics looks at anxiety, Clinuvel gets orphan designation and Avexa announces collaboration and good results.
  • +

    Inhibitor looks promising for drug-resistant HIV 23/03/2007 16:35:51

    Trial of reverse transcriptase inhibitor achieves good results in patients with drug-resistant HIV.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Jobs